Login to Your Account

Clinic Roundup

Friday, June 15, 2012
• PharmAthene Inc., of Annapolis, Md., said it completed final analytical testing and release of its recombinant protective antigen anthrax vaccine, SparVax, in pre-filled syringes for further clinical evaluation.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription